Market Overview:

The peanut allergy market reached a value of US$ 445.4 Million in 2023 and expected to reach US$ 939.2 Million by 2034, exhibiting a growth rate (CAGR) of 7.02% during 2024-2034.

The report offers a comprehensive analysis of the peanut allergy market in the United States, EU5 (including Germany, Spain, Italy, France, and the United Kingdom), and Japan. It covers aspects such as treatment methods, drugs available in the market, drugs in development, the proportion of various therapies, and the market’s performance in the seven major regions. Additionally, the report evaluates the performance of leading companies and their pharmaceutical products. Current and projected patient numbers across these key markets are also detailed in the report. This study is essential for manufacturers, investors, business planners, researchers, consultants, and anyone interested or involved in the peanut allergy market.

Request for a Sample of this Report: https://www.imarcgroup.com/peanut-allergy-market/requestsample

Peanut Allergy Market Trends: 

Peanut allergy, commonly referred to as peanut hypersensitivity, is a severe food allergy in which the immune system of the body mistakenly interprets peanut proteins as dangerous and thus triggers an allergic reaction. The peanut allergy market is experiencing significant growth, primarily fueled by the rising incidence of peanut allergies. This escalation is attributed to a combination of genetic and environmental factors, which are making peanut allergies highly common, especially among children. Moreover, efforts to improve diagnosis and public awareness about food allergies are enhancing early detection rates, thereby increasing the number of individuals seeking treatment. Additionally, the peanut allergy market is driven by the development and approval of new therapeutic options, such as oral immunotherapy, which desensitizes the immune system to peanuts gradually.

Furthermore, the advent of biologics targeting immune pathways specific to allergic reactions is expanding the medication landscape, providing hope for highly effective management solutions. In addition, technological advancements in allergy testing, including component-resolved diagnostics, offer precise allergen identification, supporting personalized treatment approaches. Such innovations are crucial for developing strategies that are both more effective and safer, reducing the risks associated with traditional exposure therapies. The market is also witnessing a growing interest in alternative therapies, including herbal and nutritional supplements, which promise additional support for immune modulation without the side effects associated with pharmacological interventions. Apart from this, the peanut allergy market is poised for further expansion, with ongoing clinical trials aimed at finding curative therapies.

Countries Covered:

• United States
• Germany
• France
• United Kingdom
• Italy
• Spain
• Japan

Analysis Covered Across Each Country:

• Historical, current, and future epidemiology scenario
• Historical, current, and future performance of the peanut allergy market
• Historical, current, and future performance of various therapeutic categories in the market
• Sales of various drugs across the peanut allergy market
• Reimbursement scenario in the market
• In-market and pipeline drugs

This report also provides a detailed analysis of the current peanut allergy marketed drugs and late-stage pipeline drugs.

In-Market Drugs:

• Drug Overview
• Mechanism of Action
• Regulatory Status
• Clinical Trial Results
• Drug Uptake and Market Performance

Late-Stage Pipeline Drugs:

• Drug overview
• Mechanism of action
• Regulatory status
• Clinical trial results
• Drug uptake and market performance

Competitive Landscape :

The competitive landscape of the peanut allergy market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of the key players:

• Cour Pharmaceutical
• DBV Technologies
• Vedanta Biosciences
• Genentech/Novartis

Ask Analyst for Customization and Explore Full Report With TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=10008&flag=C

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: [email protected]

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163